Zydus Pharmaceuticals Recalls Icosapent Ethyl Capsules Over Subpotency
Zydus Pharmaceuticals recalled 22,896 bottles of Icosapent Ethyl capsules on December 30, 2025. The recall stems from leakage and oxidation that may reduce the drug's effectiveness. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Product Details
The recall involves Icosapent Ethyl capsules, 1 gram, in 120-count bottles. The affected lot numbers include S2520304, S2520333, and S2540186, with expiration dates of February 28, 2027, and April 30, 2027. These products were manufactured by Softgel Healthcare Pvt. Ltd. in India.
The Hazard
The capsules may be subpotent due to oxidation caused by leakage. This condition can lead to inconsistent therapeutic effects and increased gastrointestinal side effects.
What to Do
Consumers should stop using the affected capsules immediately. Contact Zydus Pharmaceuticals at the provided contact information for guidance and potential refunds.
Contact Information
For more details, consumers can visit the FDA recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0295-2026. Reach Zydus Pharmaceuticals at their Pennington, NJ office for direct inquiries.